Genetic testing is seen to reach a high level of US$ 49.72 billion by 2033 while rising from US$ 21.47 billion in the year 2024; it is observed that the value will grow with a compound annual growth rate of 9.79% for the period 2025-2033. Applications in oncology, rare disease diagnostics, and prenatal testing fuel an expansion in this market by making genetic testing an imperative tool for enhanced healthcare solutions worldwide. Read More: https://www.renub.com/genetic-testing-market-p.php The report Genetic Testing Market & Forecast covers by Tests (Predictive, Carrier, Prenatal and Newborn, Diagnostic, Pharmacogenomic, Nutrigenomic), Products (Consumables, Equipments, Software & Services), Technology (PCR, DNA Sequencing, Microarrays), Disease (Cancer, Genetic, Cardiovascular, Rare, Infectious), End-Users (Hospitals & Clinics, Diagnostic Laboratories, Others), Country and Company 2025-2033. #Genetic_Testing_Market